Horizon Pharma plc
Dec 8, 2016

Horizon Pharma plc to Participate in Investor Conference in December

DUBLIN, Ireland, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate in the following conference in December:

The BMO Prescriptions for Success Healthcare Conference

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  Horizon Pharma markets 11 medicines through its orphan, rheumatology and primary care business units.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:



Investors:

Tina Ventura

Senior Vice President, Investor Relations

investor-relations@horizonpharma.com



U.S. Media:

Geoff Curtis

Senior Vice President, Corporate Communications

gcurtis@horizonpharma.com



Ireland Media:

Ray Gordon

Gordon MRM

ray@gordonmrm.ie

Primary Logo

Source: Horizon Pharma plc

News Provided by Acquire Media